Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)
- 16 October 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Familial Cancer
- Vol. 7 (2), 163-172
- https://doi.org/10.1007/s10689-007-9164-6
Abstract
The family histories of 130 individuals with documented hereditary non-polyposis colorectal cancer (HNPCC) (caused by mutations in mismatch-repair (MMR) genes MSH2 (n = 64), MLH1 (n = 62) or MSH6 (n = 4)) were obtained, and incidence of cancers in those families was compared to that in the general population. There were a total of 982 cancers in 723 individuals. Colorectal cancer (CRC) was the commonest type (64% and 55% in individuals from families with germline MLH1 and MSH2 mutations respectively). Median age at diagnosis of first CRC in MSH6 mutation families was 59 years compared to 45 years in both MLH1 and MSH2 mutation families. The relative risk (RR) of endometrial cancer was 55 in MSH2 mutation families, compared with 27 in MLH1 mutation families, and 37 in MSH6 mutation families; median age at diagnosis 49 years. Even within MSH2 families, endometrial cancer tended to cluster, with 28 of the 58 cases coming from families with three or more cases (P < 0.001). Absolute risk of endometrial cancer in MLH1 families was still greater than any other cancer (other than CRC). 5% of cancers in both MLH1 and MSH2 mutation families were gastric (RR = 12); 53% of these were diagnosed before 50 years. Seven cases of small intestinal cancer occurred in MSH2 and MLH1 mutation families (RR = 26). There were 13 cases of cancer of the ureter; all were in MSH2 families. These cancers tended to cluster within families (P < 0.001); three of seven families with urothelial cancer had such cases in two or more individuals; two others had kidney cancer. Nineteen of 27 ovarian cancers (70%) were in MSH2 mutation families and 70% of these were diagnosed before age 50 years. There were 9 cases of sebaceous skin cancer, 3 in two MLH1 and 6 in four MSH2 mutation families. Of 22 pancreatic cancers, 14 were known to be diagnosed before 60 years. Breast cancer RR was 1.7 overall. The type of mutation (truncating or other type, and site of mutation) showed no obvious correlation with the presence or absence of extra-colonic cancers in families.Keywords
This publication has 26 references indexed in Scilit:
- The Tumor Spectrum in the Lynch SyndromeFamilial Cancer, 2005
- Lower Incidence of Colorectal Cancer and Later Age of Disease Onset in 27 Families With Pathogenic MSH6 Germline Mutations Compared With Families With MLH1 or MSH2 Mutations: The German Hereditary Nonpolyposis Colorectal Cancer ConsortiumJournal of Clinical Oncology, 2004
- Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillanceGastroenterology, 2004
- A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndromeJournal of Medical Genetics, 2004
- Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancerGastroenterology, 2004
- Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindredsInternational Journal of Cancer, 1997
- Familial Transitional Cell Carcinoma and the Lynch Syndrome IIPublished by Wiley ,1993
- The Lynch syndromesCurrent Opinion in Oncology, 1993
- Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated reviewGastroenterology, 1993
- The tumour spectrum in hereditary non‐polyposis colorectal cancer: A study of 24 kindreds in the netherlandsInternational Journal of Cancer, 1990